Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
13.41
-0.35 (-2.54%)
At close: Oct 29, 2025, 4:00 PM EDT
13.41
0.00 (0.00%)
After-hours: Oct 29, 2025, 4:10 PM EDT
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $915.55 million as of October 29, 2025. Its market cap has increased by 53.16% in one year.
Market Cap
915.55M
Enterprise Value
917.86M
1-Year Change
53.16%
Ranking
Category
Stock Price
$13.41
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $915.55M, an increase of 610.53%. That is a compound annual growth rate of 7.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 917.95M | 41.30% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | 992.79M | -10.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |